Characteristics | Oncologic scores ≥ 2 n = 266 (%) | Oncologic scores < 2 n = 210 (%) | p value |
---|---|---|---|
Age (years), median (range) | 60 (29–88) | 61 (29–88) | 0.503 |
Gender | 0.317 | ||
Male | 176 (66.2) | 148 (70.5) | |
Female | 90 (33.8) | 62 (29.5) | |
Primary tumor location | 0.776 | ||
Right colon | 43 (16.2) | 36 (17.1) | |
Left colon | 223 (83.8) | 174 (82.9) | |
Metastatic types | < 0.0001 | ||
Synchronous | 225 (84.6) | 46 (21.9) | |
Metachronous | 41 (15.4) | 164 (78.1) | |
Serum CEA | < 0.0001 | ||
< 60 ng/mL | 201 (75.6) | 202 (96.2) | |
≥ 60 ng/mL | 65 (24.4) | 8 (3.8) | |
Maximum tumor size | < 0.0001 | ||
< 5 cm | 178 (66.9) | 200 (95.2) | |
≥ 5 cm | 88 (33.1) | 10 (4.8) | |
Tumor number | < 0.0001 | ||
< 5 nodules | 226 (85.0) | 207 (98.6) | |
≥ 5 nodules | 40 (15.0) | 3 (1.4) | |
Primary lymph node | < 0.0001 | ||
Positive | 228 (85.7) | 93 (44.3) | |
Negative | 38 (14.3) | 117 (55.7) | |
CRC recurrence after liver resection. | 0.004 | ||
Yes | 182 (68.4) | 117 (55.7) | |
No | 84 (31.6) | 93 (44.3) | |
Patient’s final status | 0.026 | ||
Alive and CRC-free | 75 (28.2) | 89 (42.4) | |
Alive with recurrent CRC | 77 (28.9) | 47 (22.4) | |
Dead of CRC | 105 (39.5) | 70 (33.3) | |
Dead of other causes | 6 (2.3) | 3 (1.4) | |
Surgical mortality | 3 (1.1) | 1 (0.5) |